Release 5 Preview #3

This page is part of the FHIR Specification (v4.5.0: R5 Preview #3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationdispense0322.json

Pharmacy Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Encounter, Patient, Practitioner

Raw JSON (canonical form + also see JSON Format Specification)

Dispense for Dilantin Oral Suspension (NDC code) - completed

{
  "resourceType": "MedicationDispense",
  "id": "meddisp0322",
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>id</b>: meddisp0322</p><p><b>status</b>: completed</p><p><b>medication</b>: </p><p><b>subject</b>: <a>Donald Duck. Generated Summary: id: pat1; Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male; </a></p><h3>Performers</h3><table><tr><td>-</td><td><b>Actor</b></td></tr><tr><td>*</td><td><a>Generated Summary: id: f006; id: 937223645 (OFFICIAL), id: 134IDY41W988 (USUAL); Rob van den Berk (OFFICIAL); ph: 0205569288(WORK), R.A.vandenberk@bmc.nl(WORK), fax: 0205664987(WORK); gender: male; birthDate: 1975-12-07</a></td></tr></table><p><b>authorizingPrescription</b>: <a>Generated Summary: id: medrx0312; id: 12345689 (OFFICIAL); status: active; intent: order; <span>Phenytoin 25mg/ml oral suspension</span>; authoredOn: 2015-01-15; <span>Status epilepticus (disorder)</span>; Patient should be counselled to ensure good dental hygiene; </a></p><p><b>type</b>: <span>Refill - Part Fill</span></p><p><b>quantity</b>: 360 ml</p><p><b>daysSupply</b>: 30 Day</p><p><b>whenPrepared</b>: 16/01/2015 1:13:00 PM</p><p><b>whenHandedOver</b>: 18/01/2015 1:13:00 PM</p><p><b>dosageInstruction</b>: </p></div>"
  },
  "status": "completed",
  "medication": {
    "concept": {
      "coding": [
        {
          "system": "http://hl7.org/fhir/sid/ndc",
          "code": "0071-2214-20",
          "display": "Dilantin 125mg/5ml Oral Suspension"
        }
      ]
    }
  },
  "subject": {
    "reference": "Patient/pat1",
    "display": "Donald Duck"
  },
  "performer": [
    {
      "actor": {
        "reference": "Practitioner/f006"
      }
    }
  ],
  "authorizingPrescription": [
    {
      "reference": "MedicationRequest/medrx0312"
    }
  ],
  "type": {
    "coding": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode",
        "code": "RFP",
        "display": "Refill - Part Fill"
      }
    ]
  },
  "quantity": {
    "value": 360,
    "system": "http://unitsofmeasure.org",
    "code": "ml"
  },
  "daysSupply": {
    "value": 30,
    "unit": "Day",
    "system": "http://unitsofmeasure.org",
    "code": "d"
  },
  "whenPrepared": "2015-01-16T07:13:00+05:00",
  "whenHandedOver": "2015-01-18T07:13:00+05:00",
  "dosageInstruction": [
    {
      "sequence": 1,
      "text": "100mg (4ml) three times daily",
      "timing": {
        "repeat": {
          "frequency": 3,
          "period": 1,
          "periodUnit": "d"
        }
      },
      "route": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "26643006",
            "display": "Oral Route (qualifier value)"
          }
        ]
      },
      "doseAndRate": [
        {
          "type": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/dose-rate-type",
                "code": "ordered",
                "display": "Ordered"
              }
            ]
          },
          "doseQuantity": {
            "value": 4,
            "unit": "ml",
            "system": "http://unitsofmeasure.org",
            "code": "ml"
          }
        }
      ]
    }
  ]
}

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.